Automation index

How much of a Medical sales rep’s job can AI already do?

A leave-behind comes earlier. Getting into clinic without selling smoke to the doctor do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

22%

AI can already do 22% of this job.

#401 / 633

Medical sales rep

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Route, leave-behind and the call. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Clinic, the minute and the one who will not see you. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Trial, the SmPC and not over-claiming. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Pharmacy, stock and the one who will not order. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
The code, compliance and not over-hosting. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Get in for real, and not selling smoke. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		22%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 633

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low